LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
6.72
-0.07 (-1.03%)
Jun 10, 2026, 11:42 AM EDT - Market open
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $210.7 million as of June 10, 2026. Its market cap has decreased by -73.43% in one year.
Market Cap
210.70M
Enterprise Value
-44.82M
1-Year Change
-73.43%
Ranking
Category
Stock Price
$6.72
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has decreased from $413.64M to $210.70M, a decrease of -49.06%. That is a compound annual growth rate of -26.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 212.90M | -57.48% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Minerva Neurosciences | 231.08M |
| Fate Therapeutics | 230.79M |
| Entrada Therapeutics | 229.53M |
| Coherus Oncology | 223.66M |
| AC Immune | 223.20M |
| Q32 Bio | 222.30M |
| Cellectis | 221.33M |
| Adagene | 219.36M |